Alert

Recommended Alerts

Sign Up For Alerts

Private Equity Firm Settles with DOJ in False Claims Act Matter Based on Claims Submitted by Its Health Care Portfolio Company

Compounding pharmacy Diabetic Care Rx, LLC d/b/a Patient Care America (“PCA”), two individual executives, and the pharmacy’s private equity fund owner, Riordan, Lewis & Haden, Inc. (“RLH”) recently reached a $21 million settlement with the U.S. Department of Justice (“DOJ”) to resolve allegations that the parties engaged in an illegal kickback scheme resulting in submission of false claims to the government in violation of the False Claims Act (“FCA”).

Read More

PErspectives: Private Equity Industry Insights


Time to Read: 1 minutes Practices: Private Equity, Asset Management

Printer-Friendly Version


Private Equity newsletter 


Welcome to the inaugural edition of PErspectives – our quarterly publication featuring news, trends and legal developments in the private equity industry. We are thrilled to launch this new publication, which features contributions from a cross section of our preeminent global private equity team. We encourage you to send us feedback on the content or topics you would like to see covered in future issues.

In this Fall 2019 issue, we explore these and other probing questions:

  • Will private investment fund opportunities be expanded to retail investors?
  • Why the recent increase in partnerships with digital health companies?
  • Will the use of SPACs continue to grow in the Asia market?
  • What is happening to the “marketing period” in syndicated all-bank acquisition financings?
  • What trends are we seeing in the market relating to the use of rep & warranty insurance in lieu of seller indemnity?

Printer-Friendly Version

Cookie Settings